… COVID-19 disease. However, some evidence from clinical trials in China showed no such
clinical benefit of remdesivir treatment … widely considered for COVID-19 treatment is oseltamivir…

… cause many diseases in animals and human beings but we are limited in this article with
SARS-CoV-2, leading to COVID-19 disease. The whole clinical picture of COVID-19 is not …

… There is currently no specific treatment for COVID-19, but antiviral therapy … COVID-19 and
discuss potential targets with existing drugs for the treatment of this emerging zoonotic disease…

… progression to death and the limited efficacy of mechanical ventilation in the treatment of
COVID-19 patients. ARDS mechanical ventilation protocols are not always of significant benefit …

… Thus, corticosteroids and immune-mediated adverse events were highly unlikely to influence
the association of ICI treatment with COVID-19 severity reported in this study. The findings …

… treatment of rheumatoid arthritis and a number of IL-6 targeting monoclonal antibodies are
under evaluation as treatments for severe COVID-19 disease. … for the treatment of COVID-19. …

… shock or other disease processes. Currently, … treatments against the novel coronavirus.
Favorable outcome was brought with the intravenous remdesivir treatment of the first COVID-19 …

… The COVID-19 has also impacted many treatment facilities for patients with diabetes. In
order to minimize potential spreading many hospitals have reduced their outpatient clinic …

… treatment was used in our center for the first time in the world after China in the treatment of
Covid-19 disease. … experience with CP transfusion administered to severe Covid-19 patients. …

… Some drugs that modify the activity of the disease, such as hydroxychloroquine, used as
treatment of rheumatic diseases have been used for the treatment of COVID-19 [3]. The use of …